Awardee OrganizationWHITMAN-WALKER INSTITUTE, INC.
Description
Abstract Text
7. Project Summary-Abstract
Latin America did not achieve any reductions in new HIV cases in the last decade. In Ecuador, transgender
women—those who identify as women or on the transfeminine spectrum and who were assigned a male sex at
birth—who have sex with cisgender men are a key population in the HIV epidemic. HIV prevalence in Ecuador
is between 20.7%-34.8% among transgender women—the highest in Latin America. Studies are urgently
needed to guide HIV prevention and care efforts to curb HIV Infection rates. People with multiple marginalized
identities, such as transgender women of African descent living in poverty, are at higher risk of exposure to
intersectional discrimination than the general U.S. population and have high rates of HIV. Yet the extent to
which Ecuadorian transgender women are burdened by intersectional discrimination and its effect on the
linkage to HIV prevention and care outcomes remains unknown. This K01 Award will provide the candidate
with training in intersectional qualitative, quantitative, intervention development, and grant writing to address
the challenge of intersectional discrimination and HIV burden in transgender women in Ecuador. The proposed
research will assess the mechanisms through which intersectional discrimination exerts its impact on linkage to
HIV prevention and care for transgender women in Ecuador while extending and deepening candidate’s
research skills. In Research Aim 1, the candidate will assess experiences of intersectional discrimination (e.g.,
HIV stigma, racism, classism) in relation to HIV prevention and care through in-depth qualitative interviews with
transgender women (Training Aim 1: application of intersectionality to qualitative methods). In Research Aim 2,
the candidate will conduct a survey to characterize and longitudinally test the pathways that link intersectional
discrimination with HIV prevention and care linkage outcomes over a 6-month period (Training Aim 2:
epidemiological methods and longitudinal quantitative research design). In Research Aim 3, the candidate will
implement the first six phases of the systematic ADAPT-ITT model to adapt an HIV intervention for
transgender women (Training Aim 3: skills for intervention development). Findings from this study and training
will position the candidate to develop an R01 proposal to implement remaining steps of the ADAPT-ITT model
and conduct a randomized controlled trial of the intervention (Training Aim 4: grant writing). As an Ecuadorian
non-binary queer U.S. immigrant researcher, the candidate has the cultural and research background to
leverage this proposed K01 to transition to career independence and address key knowledge and intervention
gaps for HIV prevention and care in Ecuador.
Public Health Relevance Statement
8. Project Narrative
In Ecuador, the HIV epidemic is concentrated primarily among transgender women—those who identify as
women or on the transfeminine spectrum and who were assigned a male sex at birth. There is an urgent need
for status-neutral HIV interventions tailored to this high-risk group. Through this K01, the candidate will assess
the mechanisms through which intersectional discrimination exerts its impact on linkage to HIV prevention and
care for transgender women in Ecuador while extending and deepening their research skills to receive
advanced training in intersectional qualitative, quantitative, intervention development, and grant writing.
Findings will inform policymakers and development of culturally tailored HIV interventions that will mitigate
intersectional discrimination and reduce HIV burden in this NIH-designated disparity population.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AIDS preventionAddressAffectAfrican ancestryAmericanAreaBirthBlack raceCaringCollaborationsCommunitiesDataDiscriminationDisparity populationEcuadorEcuadorianEnrollmentEpidemicEpidemiologic MethodsEpidemiologyExposure toFaceFundingFutureGender IdentityGrantHIVHIV InfectionsHIV SeronegativityHIV SeropositivityHIV riskHealth Disparities ResearchHealth PrioritiesHigh PrevalenceImmigrantIncidenceIndigenousIndividualInterventionIntervention TrialInterviewKnowledgeLatin AmericaLinkMentored Research Scientist Development AwardMentorshipMethodsModelingOutcomePathway interactionsPersonsPhasePolicy DevelopmentsPolicy MakerPopulationPositioning AttributePovertyPrevalencePreventionProgram DevelopmentQualitative MethodsRaceRandomized, Controlled TrialsResearchResearch DesignResearch PersonnelRisk BehaviorsSamplingSexual and Gender MinoritiesSocioeconomic StatusSurveysSystemTestingTrainingTraining ActivityUnited States National Institutes of HealthVisitWomanWritingbilingualismcare outcomescareercis-maleclassismcommunity advisory boarddesignexperiencehealth disparity populationshigh riskhigh risk populationinfection rateintersectionalitylongitudinal analysislongitudinal designmalemarginalizationmodel developmentnonbinarypeerpre-exposure prophylaxisprogramsqueerracismrecruitresearch and developmentresiliencesexskill acquisitionskillssocial mediasocial stigmasocioeconomicstherapy designtherapy developmenttransfemininetransgendertransgender women
No Sub Projects information available for 5K01MH134764-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K01MH134764-02
Patents
No Patents information available for 5K01MH134764-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K01MH134764-02
Clinical Studies
No Clinical Studies information available for 5K01MH134764-02
News and More
Related News Releases
No news release information available for 5K01MH134764-02
History
No Historical information available for 5K01MH134764-02
Similar Projects
No Similar Projects information available for 5K01MH134764-02